Novel insights in endocrine and metabolic pathways in sepsis and gaps for future research.
暂无分享,去创建一个
[1] G. Van den Berghe,et al. Critical Illness–induced Corticosteroid Insufficiency: What It Is Not and What It Could Be , 2022, The Journal of clinical endocrinology and metabolism.
[2] R. Branco,et al. The effect of nutritional status and inflammatory stimuli on Ghrelin and PYY levels among critically ill children: A prospective and observational study. , 2022, JPEN. Journal of parenteral and enteral nutrition.
[3] G. Van den Berghe,et al. Obesity attenuates inflammation, protein catabolism, dyslipidaemia, and muscle weakness during sepsis, independent of leptin , 2022, Journal of cachexia, sarcopenia and muscle.
[4] G. Van den Berghe,et al. Persisting neuroendocrine abnormalities and their association with physical impairment 5 years after critical illness , 2021, Critical Care.
[5] R. Bellomo,et al. Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis , 2021, Intensive Care Medicine.
[6] G. Van den Berghe,et al. Impact of Hydrocortisone and of CRH Infusion on the Hypothalamus-Pituitary-Adrenocortical Axis of Septic Male Mice , 2021, Endocrinology.
[7] C. Sprung,et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 , 2021, Intensive Care Medicine.
[8] B. Souweine,et al. Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study—a randomized clinical trial , 2021, Intensive Care Medicine.
[9] A. Deane,et al. The goal of personalized glucose control in the critically ill remains elusive , 2021, Intensive Care Medicine.
[10] S. Jørgensen,et al. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease , 2021, Nature Reviews Endocrinology.
[11] G. Van den Berghe,et al. Differential DNA methylation by early versus late parenteral nutrition in the PICU: a biological basis for its impact on emotional and behavioral problems documented 4 years later , 2021, Clinical epigenetics.
[12] P. Most,et al. Long-term sequelae of critical illness in sepsis, trauma and burns: A systematic review and meta-analysis , 2021, The journal of trauma and acute care surgery.
[13] G. Van den Berghe,et al. Impact of withholding early parenteral nutrition in adult critically ill patients on ketogenesis in relation to outcome , 2021, Critical Care.
[14] Z. Puthucheary,et al. Are periods of feeding and fasting protective during critical illness? , 2021, Current opinion in clinical nutrition and metabolic care.
[15] Samuel M. Brown,et al. Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial. , 2021, JAMA.
[16] G. Van den Berghe,et al. The role of pro-opiomelanocortin in the ACTH–cortisol dissociation of sepsis , 2021, Critical Care.
[17] G. Hong,et al. Thyroid hormone levels as a predictor marker predict the prognosis of patients with sepsis. , 2021, The American journal of emergency medicine.
[18] G. Van den Berghe,et al. Endocrine interventions in the intensive care unit. , 2021, Handbook of clinical neurology.
[19] J. Preiser,et al. The Interaction of Acute and Chronic Glycemia on the Relationship of Hyperglycemia, Hypoglycemia, and Glucose Variability to Mortality in the Critically Ill. , 2020, Critical care medicine.
[20] G. Van den Berghe,et al. The clinical potential of GDF15 as a “ready-to-feed indicator” for critically ill adults , 2020, Critical Care.
[21] G. Van den Berghe,et al. Effect of withholding early parenteral nutrition in PICU on ketogenesis as potential mediator of its outcome benefit , 2020, Critical Care.
[22] Seonwoo Kim,et al. Combination therapy of vitamin C and thiamine for septic shock: a multi-centre, double-blinded randomized, controlled study , 2020, Intensive Care Medicine.
[23] P. Schlattmann,et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis , 2020, Intensive Care Medicine.
[24] G. Van den Berghe,et al. Towards a fasting-mimicking diet for critically ill patients: the pilot randomized crossover ICU-FM-1 study , 2020, Critical Care.
[25] M. Berger,et al. Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the Section of Metabolism, Endocrinology and Nutrition of the European Society of Intensive Care Medicine , 2020, Critical Care.
[26] Jesse B. Sullivan,et al. Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis. , 2020, Chest.
[27] R. Bellomo,et al. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial. , 2020, JAMA.
[28] Niranjan Kissoon,et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study , 2020, The Lancet.
[29] S. Orfanos,et al. Longitudinal evaluation of glucocorticoid receptor alpha/beta expression and signalling, adrenocortical function and cytokines in critically ill steroid-free patients , 2019, Molecular and Cellular Endocrinology.
[30] R. de Cabo,et al. Effects of Intermittent Fasting on Health, Aging, and Disease. , 2019, The New England journal of medicine.
[31] R. Bellomo,et al. Relative Hypoglycemia in Diabetic Patients With Critical Illness , 2019, Critical care medicine.
[32] S. Orfanos,et al. Ghrelin alterations during experimental and human sepsis. , 2019, Cytokine.
[33] D. Annane,et al. Corticosteroids for treating sepsis in children and adults. , 2019, The Cochrane database of systematic reviews.
[34] M. Netea,et al. Current gaps in sepsis immunology: new opportunities for translational research. , 2019, The Lancet. Infectious diseases.
[35] G. Van den Berghe,et al. The growth hormone axis in relation to accepting an early macronutrient deficit and outcome of critically ill patients. , 2019, The Journal of clinical endocrinology and metabolism.
[36] G. Van den Berghe,et al. Nonthyroidal Illness Syndrome Across the Ages , 2019, Journal of the Endocrine Society.
[37] E. Fliers,et al. Down regulation of type 3 deiodinase in the hypothalamus during inflammation. , 2019, Thyroid : official journal of the American Thyroid Association.
[38] G. Van den Berghe,et al. Anterior pituitary function in critical illness , 2019, Endocrine connections.
[39] G. Van den Berghe,et al. Adrenal function and dysfunction in critically ill patients , 2019, Nature Reviews Endocrinology.
[40] G. Van den Berghe,et al. Non-Thyroidal Illness Syndrome in Critically Ill Children: Prognostic Value and Impact of Nutritional Management. , 2019, Thyroid : official journal of the American Thyroid Association.
[41] G. Van den Berghe,et al. Glucose control in the ICU. , 2019, Current opinion in anaesthesiology.
[42] J. Bion,et al. Mapping the Steroid Response to Major Trauma From Injury to Recovery: A Prospective Cohort Study , 2019, bioRxiv.
[43] C. Pichard,et al. ESPEN guideline on clinical nutrition in the intensive care unit. , 2019, Clinical nutrition.
[44] J. Vincent,et al. Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit , 2018, Open forum infectious diseases.
[45] Patricia A. H. Williams,et al. Energy‐Dense versus Routine Enteral Nutrition in the Critically Ill , 2018, The New England journal of medicine.
[46] G. Van den Berghe,et al. ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study , 2018, Intensive Care Medicine.
[47] G. Van den Berghe,et al. Adrenocortical function during prolonged critical illness and beyond: a prospective observational study , 2018, Intensive Care Medicine.
[48] C. Deutschman,et al. Cecal Ligation and Puncture Alters Glucocorticoid Receptor Expression , 2018, Critical care medicine.
[49] B. Souweine,et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock , 2018, The New England journal of medicine.
[50] R. Bellomo,et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock , 2018, The New England journal of medicine.
[51] B. Souweine,et al. Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2) , 2018, The Lancet.
[52] G. Van den Berghe,et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017 , 2018, Intensive Care Medicine.
[53] J. Holst,et al. Role of Glucagon in Catabolism and Muscle Wasting of Critical Illness and Modulation by Nutrition , 2017, American journal of respiratory and critical care medicine.
[54] P. Marik,et al. Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM) , 2017, Intensive Care Medicine.
[55] J. Gunst. Recovery from critical illness-induced organ failure: the role of autophagy , 2017, Critical Care.
[56] G. Van den Berghe,et al. Effect of early supplemental parenteral nutrition in the paediatric ICU: a preplanned observational study of post-randomisation treatments in the PEPaNIC trial. , 2017, The Lancet. Respiratory medicine.
[57] M. Netea,et al. The immunopathology of sepsis and potential therapeutic targets , 2017, Nature Reviews Immunology.
[58] H. Wong,et al. Glucocorticoid Receptor Polymorphisms and Outcomes in Pediatric Septic Shock* , 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[59] V. Nadkarni,et al. Tight Glycemic Control in Critically Ill Children , 2017, The New England journal of medicine.
[60] G. Van den Berghe,et al. Drug‐induced HPA axis alterations during acute critical illness: a multivariable association study , 2016, Clinical endocrinology.
[61] M. Berger,et al. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines , 2017, Intensive Care Medicine.
[62] Justin M. Weis,et al. Bioavailable estradiol concentrations are elevated and predict mortality in septic patients: a prospective cohort study , 2016, Critical Care.
[63] W. Dixon,et al. Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review , 2016, Seminars in arthritis and rheumatism.
[64] R. Bellomo,et al. Timing of onset and burden of persistent critical illness in Australia and New Zealand: a retrospective, population-based, observational study. , 2016, The Lancet. Respiratory medicine.
[65] R. Hotchkiss,et al. Sepsis and septic shock , 2016, Nature Reviews Disease Primers.
[66] J. Vincent,et al. High prolactin levels are associated with more delirium in septic patients. , 2016, Journal of critical care.
[67] G. Van den Berghe,et al. Blood glucose control in the ICU: don’t throw out the baby with the bathwater! , 2016, Intensive Care Medicine.
[68] G. Van den Berghe,et al. Early versus Late Parenteral Nutrition in Critically Ill Children. , 2016, The New England journal of medicine.
[69] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[70] D. Angus,et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. , 2016, American journal of respiratory and critical care medicine.
[71] G. Van den Berghe. On the Neuroendocrinopathy of Critical Illness. Perspectives for Feeding and Novel Treatments. , 2016, American journal of respiratory and critical care medicine.
[72] T. Narula,et al. Ghrelin in Critical Illness. , 2015, American journal of respiratory cell and molecular biology.
[73] E. Fliers,et al. Thyroid function in critically ill patients. , 2015, The lancet. Diabetes & endocrinology.
[74] G. Van den Berghe,et al. FGF21 Response to Critical Illness: Effect of Blood Glucose Control and Relation With Cellular Stress and Survival. , 2015, The Journal of clinical endocrinology and metabolism.
[75] D. Torpy,et al. Depletion of high‐affinity corticosteroid‐binding globulin corresponds to illness severity in sepsis and septic shock; clinical implications , 2015, Clinical endocrinology.
[76] G. Van den Berghe,et al. Effect of Early Parenteral Nutrition on the HPA Axis and on Treatment With Corticosteroids in Intensive Care Patients. , 2015, The Journal of clinical endocrinology and metabolism.
[77] R. Bellomo,et al. Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial , 2015, Intensive Care Medicine.
[78] O. Dekkers,et al. [Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis]. , 2015, Nederlands tijdschrift voor geneeskunde.
[79] G. Angelini,et al. Dynamic Pituitary-Adrenal Interactions in Response to Cardiac Surgery* , 2015, Critical care medicine.
[80] M. Gheorghiu,et al. Endocrine dysfunction in sepsis: a beneficial or deleterious host response? , 2015, Germs.
[81] S. Mehta,et al. Permissive Underfeeding or Standard Enteral Feeding in Critically Ill Adults. , 2015, The New England journal of medicine.
[82] R. Fernández,et al. Neural reflex regulation of systemic inflammation: potential new targets for sepsis therapy , 2014, Front. Physiol..
[83] D. Harrison,et al. Trial of the route of early nutritional support in critically ill adults. , 2014, The New England journal of medicine.
[84] G. Hedenstierna,et al. Glucocorticoid receptor function is decreased in neutrophils during endotoxic shock. , 2014, The Journal of infection.
[85] G. Van den Berghe,et al. Impact of duration of critical illness on the adrenal glands of human intensive care patients. , 2014, The Journal of clinical endocrinology and metabolism.
[86] N. Watts,et al. Low Testosterone Levels are Frequent in Patients with Acute Respiratory Failure and are Associated with Poor Outcomes. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[87] Hassane Njimi,et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. , 2014, The Lancet. Respiratory medicine.
[88] G. Van den Berghe,et al. Reduced nocturnal ACTH-driven cortisol secretion during critical illness. , 2014, American journal of physiology. Endocrinology and metabolism.
[89] R. Bellomo,et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. , 2014, JAMA.
[90] R. Grieve,et al. A randomized trial of hyperglycemic control in pediatric intensive care. , 2014, The New England journal of medicine.
[91] M. Sorine,et al. Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial , 2014, Intensive Care Medicine.
[92] Y. Choi,et al. Efficacy of perioperative oral triiodothyronine replacement therapy in patients undergoing off-pump coronary artery bypass grafting. , 2013, Journal of cardiothoracic and vascular anesthesia.
[93] G. Van den Berghe,et al. Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. , 2013, The Lancet. Respiratory medicine.
[94] I. Goecke,et al. Septic serum induces glucocorticoid resistance and modifies the expression of glucocorticoid isoforms receptors: a prospective cohort study and in vitro experimental assay , 2013, Critical Care.
[95] G. Van den Berghe,et al. Impact of early parenteral nutrition on metabolism and kidney injury. , 2013, Journal of the American Society of Nephrology : JASN.
[96] G. Van den Berghe,et al. Reduced cortisol metabolism during critical illness. , 2013, The New England journal of medicine.
[97] G. Van den Berghe,et al. Role of disease and macronutrient dose in the randomized controlled EPaNIC trial: a post hoc analysis. , 2013, American journal of respiratory and critical care medicine.
[98] G. Van den Berghe,et al. Impact of early nutrient restriction during critical illness on the nonthyroidal illness syndrome and its relation with outcome: a randomized, controlled clinical study. , 2013, The Journal of clinical endocrinology and metabolism.
[99] L. Lagae,et al. Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial. , 2012, JAMA.
[100] J. Briegel,et al. Effect of heparin during extracorporeal detoxification in the severity of thrombocytopenia in patients with severe sepsis , 2012, Critical Care.
[101] F. Pigula,et al. Tight glycemic control versus standard care after pediatric cardiac surgery. , 2012, The New England journal of medicine.
[102] M. Singer,et al. Ghrelin, appetite and critical illness , 2012, Current opinion in critical care.
[103] G. Van den Berghe,et al. Early parenteral nutrition evokes a phenotype of autophagy deficiency in liver and skeletal muscle of critically ill rabbits. , 2012, Endocrinology.
[104] T. Rice,et al. Initial Trophic vs Full Enteral Feeding in Patients With Acute Lung Injury: The EDEN Randomized Trial , 2012 .
[105] G. Van den Berghe,et al. Thyroid axis function and dysfunction in critical illness. , 2011, Best practice & research. Clinical endocrinology & metabolism.
[106] G. Van den Berghe,et al. Early versus Late Parenteral Nutrition in Critically Ill Adults , 2011, The New England journal of medicine.
[107] M. Christ-Crain,et al. Low triiodothyronine syndrome: a prognostic marker for outcome in sepsis? , 2011, Endocrine.
[108] K. Langa,et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis. , 2010, JAMA.
[109] G. Van den Berghe,et al. Glucose dysregulation and neurological injury biomarkers in critically ill children. , 2010, The Journal of clinical endocrinology and metabolism.
[110] P. Pronovost,et al. Long-term mortality and quality of life in sepsis: A systematic review* , 2010, Critical care medicine.
[111] Shelley E. Taylor,et al. Low Calorie Dieting Increases Cortisol , 2010, Psychosomatic medicine.
[112] J. Vincent,et al. Comparison of dopamine and norepinephrine in the treatment of shock. , 2010, The New England journal of medicine.
[113] D. Annane,et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. , 2010, JAMA.
[114] D. Chaplin. Overview of the immune response. , 2003, The Journal of allergy and clinical immunology.
[115] Mercedes Falciglia,et al. Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis* , 2009, Critical care medicine.
[116] G. Van den Berghe,et al. Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness , 2009, Critical care.
[117] G. Van den Berghe,et al. Expression of thyroid hormone transporters during critical illness. , 2009, European journal of endocrinology.
[118] Johan Groeneveld,et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study , 2009, Intensive Care Medicine.
[119] Naomi Jones,et al. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study , 2009, Intensive Care Medicine.
[120] S. Lamberts,et al. Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsis , 2009, Intensive Care Medicine.
[121] Stephane Heritier,et al. Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.
[122] Greet Van den Berghe,et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study , 2009, The Lancet.
[123] G. Van den Berghe,et al. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit* , 2009, Critical care medicine.
[124] A. Forbes,et al. ESPEN Guidelines on Parenteral Nutrition: intensive care. , 2006, Clinical nutrition.
[125] E. Fliers,et al. Type 3 deiodinase is highly expressed in infiltrating neutrophilic granulocytes in response to acute bacterial infection. , 2008, Thyroid : official journal of the American Thyroid Association.
[126] G. Van den Berghe,et al. Effects of substitution and high-dose thyroid hormone therapy on deiodination, sulfoconjugation, and tissue thyroid hormone levels in prolonged critically ill rabbits. , 2008, Endocrinology.
[127] J. Harney,et al. Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. , 2008, The Journal of clinical investigation.
[128] E. Fliers,et al. Fasting-induced changes in the hypothalamus-pituitary-thyroid axis. , 2008, Thyroid : official journal of the American Thyroid Association.
[129] Brian H Cuthbertson,et al. Hydrocortisone therapy for patients with septic shock. , 2008, The New England journal of medicine.
[130] Rolf Rossaint,et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.
[131] S. Herzig,et al. Glucocorticoids, metabolism and metabolic diseases , 2007, Molecular and Cellular Endocrinology.
[132] G. Van den Berghe,et al. The type II iodothyronine deiodinase is up-regulated in skeletal muscle during prolonged critical illness. , 2007, The Journal of clinical endocrinology and metabolism.
[133] J. Ferreira,et al. Increased extracellular signal regulated kinases phosphorylation in the adrenal gland in response to chronic ACTH treatment. , 2007, The Journal of endocrinology.
[134] G. Van den Berghe,et al. Thyroid hormone receptor isoform expression in livers of critically ill patients. , 2007, Thyroid : official journal of the American Thyroid Association.
[135] Miet Schetz,et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. , 2006, European heart journal.
[136] Miet Schetz,et al. Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units , 2006, Diabetes.
[137] G. Van den Berghe,et al. Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.
[138] W. Wiersinga,et al. Differential involvement of nuclear factor-kappaB and activator protein-1 pathways in the interleukin-1beta-mediated decrease of deiodinase type 1 and thyroid hormone receptor beta1 mRNA. , 2006, The Journal of endocrinology.
[139] C. Sprung,et al. Sepsis in European intensive care units: Results of the SOAP study* , 2006, Critical care medicine.
[140] G. Van den Berghe,et al. ESPEN Guidelines on Enteral Nutrition: Intensive care. , 2006, Clinical nutrition.
[141] M. Berger,et al. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. , 2005, Clinical nutrition.
[142] H. Krumholz,et al. Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction: Implications for Patients With and Without Recognized Diabetes , 2005, Circulation.
[143] G. Chrousos,et al. Nuclear factor-kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. , 2005, Neuroimmunomodulation.
[144] F. Zegher,et al. Dopamine suppresses pituitary function in infants and children , 1994, Pediatric Nephrology.
[145] N. H. Steigbigel. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.
[146] G. Van den Berghe,et al. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. , 2003, The Journal of clinical endocrinology and metabolism.
[147] C. Lang,et al. Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis. , 2002, American journal of physiology. Endocrinology and metabolism.
[148] J. Klemperer. Thyroid hormone and cardiac surgery. , 2002, Thyroid : official journal of the American Thyroid Association.
[149] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[150] D. Annane,et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. , 2000, JAMA.
[151] John P. Johnson,et al. A trial of thyroxine in acute renal failure. , 2000, Kidney international.
[152] N R Webster,et al. Increased mortality associated with growth hormone treatment in critically ill adults. , 1999, The New England journal of medicine.
[153] G. Van den Berghe,et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. , 1999, The Journal of clinical endocrinology and metabolism.
[154] G. Van den Berghe. Growth hormone secretagogues in critical illness. , 1999, Hormone research.
[155] G. Van den Berghe,et al. Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. , 1998, The Journal of clinical endocrinology and metabolism.
[156] N. Ferrara,et al. Corticotropin regulates vascular endothelial growth factor expression in human fetal adrenal cortical cells. , 1998, The Journal of clinical endocrinology and metabolism.
[157] G. Van den Berghe,et al. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. , 1998, The Journal of clinical endocrinology and metabolism.
[158] E. Fliers,et al. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. , 1997, The Journal of clinical endocrinology and metabolism.
[159] G. Van den Berghe,et al. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone‐secretagogues , 1997, Clinical endocrinology.
[160] J. Wernerman,et al. Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery. , 1997, The Journal of clinical endocrinology and metabolism.
[161] F. Zegher,et al. Anterior pituitary function during critical illness and dopamine treatment , 1996 .
[162] G. Van den Berghe,et al. Pituitary responsiveness to GH‐releasing hormone, GH‐releasing peptide‐2 and thyrotrophin‐releasing hormone in critical illness , 1996, Clinical endocrinology.
[163] J. Holly,et al. Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease. , 1996, Critical care medicine.
[164] C. Mantzoros,et al. Role of leptin in the neuroendocrine response to fasting , 1996, Nature.
[165] Robert W. Anderson,et al. Cardiovascular Effects of Intravenous Triiodothyronine in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Randomized, Double-blind, Placebo-Controlled Trial , 1996 .
[166] S. Thomas,et al. Thyroid hormone treatment after coronary-artery bypass surgery. , 1995, The New England journal of medicine.
[167] K. Brismar,et al. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects. , 1994, The Journal of clinical endocrinology and metabolism.
[168] J. Orav,et al. Reproductive axis suppression in acute illness is related to disease severity. , 1993, The Journal of clinical endocrinology and metabolism.
[169] R. Ross,et al. Acquired growth hormone resistance in patients with hypercatabolism. , 1993, Hormone research.
[170] G. Reisz,et al. Effects of dopamine on T‐lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients , 1992, Critical care medicine.
[171] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.
[172] K. Alberti,et al. Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men. , 1992, The Journal of clinical endocrinology and metabolism.
[173] J. Miell,et al. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin–like growth factor‐I , 1991, Clinical endocrinology.
[174] T. Clemmer,et al. Sepsis syndrome: a valid clinical entity , 1989 .
[175] J. Sowers,et al. Catecholamines in critical care. , 1987, Critical care clinics.
[176] J. Liu,et al. Increased cortisol production in women runners. , 1986, The Journal of clinical endocrinology and metabolism.
[177] J. Davis,et al. Alterations in serum cortisol and its binding characteristics in anorexia nervosa. , 1979, The Journal of clinical endocrinology and metabolism.
[178] L. Axelrod. GLUCOCORTICOID THERAPY , 1976, Medicine.
[179] L. I. Goldberg,et al. Dopamine--clinical uses of an endogenous catecholamine. , 1974, The New England journal of medicine.
[180] G. L. Noel,et al. Human prolactin and growth hormone release during surgery and other conditions of stress. , 1972, The Journal of clinical endocrinology and metabolism.